TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

REXAR

Pharmaceuticals
Generics

REXAR is a generic drug manufacturer with 1 FDA-approved products.

1976
Since
1
Drugs
-
Trials
7
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

METHAMPHETAMINE HYDROCHLORIDE 2025-03-28
Manufacturing (CMC)
METHAMPHETAMINE HYDROCHLORIDE 2024-06-06
Labeling
METHAMPHETAMINE HYDROCHLORIDE 2024-04-18
Labeling
METHAMPHETAMINE HYDROCHLORIDE 2024-04-18
Labeling
METHAMPHETAMINE HYDROCHLORIDE 2024-04-18
Labeling
METHAMPHETAMINE HYDROCHLORIDE 2024-04-18
Labeling
METHAMPHETAMINE HYDROCHLORIDE 2024-04-18
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...